首页> 外文期刊>Journal of enzyme inhibition and medicinal chemistry. >3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors.
【24h】

3Beta-sulfamate derivatives of C19 and C21 steroids bearing a t-butylbenzyl or a benzyl group: synthesis and evaluation as non-estrogenic and non-androgenic steroid sulfatase inhibitors.

机译:3带有叔丁基苄基或苄基的C19和C21类固醇的β-氨基磺酸酯衍生物:合成和评估为非雌激素和非雄激素类固醇硫酸酯酶抑制剂。

获取原文
获取原文并翻译 | 示例
           

摘要

A series of C19 and C21 steroids bearing one or two inhibiting groups (3beta-sulfamate and 17alpha- or 20(S)-t-butylbenzyl or benzyl) were synthesized and tested for inhibition of steroid sulfatase activity. When only a sulfamate group was added to dehydroepiandrosterone, androst-5-ene-3beta,17beta-diol, pregnenolone and 20-hydroxy-pregnenolone, no significant inhibition of steroid sulfatase occurred at concentrations of 0.3 and 3 microM. With only a t-butylbenzyl or a benzyl group, a stronger steroid sulfatase inhibition was obtained in the androst-5-ene than in the pregn-5-ene series. Comparative results from the screening tests and the IC50 values have shown that the effect of a sulfamate moiety as a second inhibiting group can be combined to the t-butylbenzyl or benzyl effect in the C19 and C21 steroid series. The 3beta-sulfamoyloxy-17alpha-t-butylbenzyl-5-androsten-17beta-ol (10) was thus found to be the most active compound with IC50 values of 46 +/- 8 and 14 +/- 1 nM, respectively for the transformations of E1S to E1 and DHEAS to DHEA. The IC50 values of compound 10 are similar to that of 17alpha-t-butylbenzyl-estradiol, which was previously reported by our group as a good steroid sulfatase reversible inhibitor, but remains higher than that of the potent inactivators estrone-3-O-sulfamate (EMATE) and 17alpha-t-butylbenzyl-EMATE. However, contrary to these two latter inhibitors, compound 10 did not induce any proliferative effect on estrogen-sensitive ZR-75-1 cells nor on androgen-sensitive Shionogi cells at concentrations tested, suggesting that this steroid sulfatase inhibitor is non estrogenic and non androgenic.
机译:合成了一系列带有一个或两个抑制基团(3β-氨基磺酸盐和17α-或20(S)-叔丁基苄基或苄基)的C19和C21类固醇,并测试了其对类固醇硫酸酯酶活性的抑制作用。当仅将氨基磺酸酯基团添加至脱氢表雄酮,雄甾烯-5β,17β-二醇,孕烯醇酮和20-羟基孕烯醇酮时,在0.3和3 microM的浓度下,甾族硫酸酯酶没有明显的抑制作用。仅具有叔丁基苄基或苄基,在雄甾烯5-烯中得到比甾烷5-烯系列更强的甾族硫酸酯酶抑制作用。筛选试验和IC50值的比较结果表明,在C19和C21类固醇系列药物中,氨基磺酸盐部分作为第二个抑制基团的作用可与叔丁基苄基或苄基作用结合。因此,发现3β-氨磺酰氧基-17α-叔丁基苄基-5-雄酮-17β-醇(10)是活性最高的化合物,其IC50值分别为46 +/- 8和14 +/- 1 nM。 E1S转换为E1,DHEAS转换为DHEA。化合物10的IC50值与17α-叔丁基苄基-雌二醇相似,之前我们小组曾将其报告为良好的类固醇硫酸酯酶可逆抑制剂,但仍高于有效的灭活剂雌酮3-O-氨基磺酸酯(EMATE)和17α-叔丁基苄基-EMATE。但是,与后两种抑制剂相反,在测试浓度下,化合物10不会对雌激素敏感性ZR-75-1细胞或对雄激素敏感性Shionogi细胞产生任何增殖作用,这表明该类固醇硫酸酯酶抑制剂是非雌激素和非雄激素的。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号